X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse GSK Pharma with MYLAN INC. - US - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs MYLAN (US) - Comparison Results

GSK PHARMA    Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GSK PHARMA   MYLAN
EQUITY SHARE DATA
    GSK PHARMA
Mar-16
MYLAN
Dec-14
GSK PHARMA/
MYLAN
5-Yr Chart
Click to enlarge
High Rs3,8503,992-   
Low Rs2,9662,813-   
Sales per share (Unadj.) Rs332.31,366.6-  
Earnings per share (Unadj.) Rs44.3164.6-  
Cash flow per share (Unadj.) Rs47.2265.0-  
Dividends per share (Unadj.) Rs50.000-  
Dividend yield (eoy) %1.50-  
Book value per share (Unadj.) Rs202.7679.3-  
Shares outstanding (eoy) m84.70378.37-   
Bonus/Rights/Conversions -OI-  
Price / Sales ratio x10.32.5 411.9%   
Avg P/E ratio x76.920.7 372.2%  
P/CF ratio (eoy) x72.212.8 562.0%  
Price / Book Value ratio x16.85.0 335.6%  
Dividend payout %112.90-   
Avg Mkt Cap Rs m288,6431,287,436 22.4%   
No. of employees `0004.625.0 18.4%   
Total wages/salary Rs m4,4340-   
Avg. sales/employee Rs Th6,104.520,683.4 29.5%   
Avg. wages/employee Rs Th961.60-   
Avg. net profit/employee Rs Th813.72,491.7 32.7%   
INCOME DATA
Net Sales Rs m28,148517,086 5.4%  
Other income Rs m1,218-3,014 -40.4%   
Total revenues Rs m29,366514,072 5.7%   
Gross profit Rs m4,774128,602 3.7%  
Depreciation Rs m24837,978 0.7%   
Interest Rs m022,304 0.0%   
Profit before tax Rs m5,74465,306 8.8%   
Minority Interest Rs m0-268 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m260-   
Tax Rs m2,0182,746 73.5%   
Profit after tax Rs m3,75262,291 6.0%  
Gross profit margin %17.024.9 68.2%  
Effective tax rate %35.14.2 835.5%   
Net profit margin %13.312.0 110.6%  
BALANCE SHEET DATA
Current assets Rs m21,462454,587 4.7%   
Current liabilities Rs m10,536355,396 3.0%   
Net working cap to sales %38.819.2 202.3%  
Current ratio x2.01.3 159.2%  
Inventory Days Days6878 86.7%  
Debtors Days Days16107 15.3%  
Net fixed assets Rs m4,717119,626 3.9%   
Share capital Rs m84718,286 4.6%   
"Free" reserves Rs m16,3080-   
Net worth Rs m17,171257,042 6.7%   
Long term debt Rs m16383,996 0.0%   
Total assets Rs m30,6201,035,343 3.0%  
Interest coverage xNM3.9-  
Debt to equity ratio x01.5 0.1%  
Sales to assets ratio x0.90.5 184.1%   
Return on assets %12.38.2 150.0%  
Return on equity %21.924.2 90.2%  
Return on capital %33.613.6 246.4%  
Exports to sales %00-   
Imports to sales %15.10-   
Net fx Rs m-7,8010-   
CASH FLOW
From Operations Rs m1,38667,971 2.0%  
From Investments Rs m5,010-53,604 -9.3%  
From Financial Activity Rs m-6,383-17,910 35.6%  
Net Cashflow Rs m12-3,543 -0.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 66.98 Rs / USD

Compare GSK PHARMA With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare GSK PHARMA With: ABBOTT INDIA  MERCK LTD  BIOCON LTD  IPCA LABS  PANACEA BIOTECH  



Today's Market

Sensex Opens Flat; Infosys Surges 3% on Buyback News(09:30 am)

Majority of Asian stock indices are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.26% while the Hang Seng is up 0.05%.

Related Views On News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

Sun Pharma: Price Erosion in US Impacts Growth (Quarterly Results Update - Detailed)

May 30, 2017

US markets decline while other geographies grow in the quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

GSK PHARMA SHARE PRICE


Aug 17, 2017 11:51 AM

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

GSK PHARMA - DR. REDDYS LAB COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS